Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
Caribou boosts case for off-the-shelf CAR-T v. autologous
Caribou reported 17.1-month PFS, adding to evidence that the off-the-shelf treatment can match the efficacy of autologous products in lymphoma.
Nick Paul Taylor
Jun 11, 2026 8:00am
Cabaletta's autoimmune CAR-T strategy is built on 'durability'
Jun 4, 2026 8:26am
ASCO: Legend scientific founder returns with new CAR-T ambition
May 29, 2026 2:00pm
Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?
May 22, 2026 8:28am
Liminatus pays $320M in stock for CAR-T biotech InnocsAI
May 21, 2026 8:09am
Kyverna begins rolling FDA submission for autoimmune CAR-T in SPS
May 12, 2026 4:27pm
